Streetbeat News

Stock Prices

CXW

Corecivic's board has authorized an increase to its existing share repurchase program, allowing the company to buy back up to an additional $125 million in shares.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 10:06 am

GUTS

Fractyl Health, Inc. (NASDAQ:GUTS) presented preclinical data from its Rejuva pancreatic gene therapy program at Digestive Disease Week 2024, focusing on a single-administration GLP-1 therapy for obesity and type 2 diabetes.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 10:04 am

ESPR

OTSKY

Esperion and Otsuka reported that the primary endpoint was achieved in a Phase 3 trial in Japan for bempedoic acid as a potential treatment for hypercholesterolemia. The trial showed statistically significant outcomes, with a -25.25% change in LDL-C at Week 12 for the bempedoic acid group compared to -3.46% for the placebo group. Otsuka holds exclusive development and commercialization rights for bempedoic acid in Japan.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 10:02 am

ARWR

Arrowhead Pharmaceuticals (NASDAQ:ARWR) presented new interim clinical data on ARO-RAGE, showing significant gene knockdown in asthma patients. The data was shared at the ATS 2024 International Conference, highlighting dose-dependent reductions in sRAGE concentration in both healthy volunteers and asthma patients.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 10:02 am

BCLI

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) will present new biomarker data suggesting ALS patients may benefit from longer-term treatment with NurOwn at the 3rd Annual ALS Drug Development Summit in May 2024.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 10:01 am

WIX

Wix.Com shares are trading higher following the company's better-than-expected Q1 results and updated FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 9:48 am

FUFU

BitFuFu (NASDAQ:FUFU) reported a significant increase in its Q1 earnings and sales. The company's EPS rose to $0.23 from $0.02 YoY, a 1050% increase, while sales surged to $144.41 million from $57.97 million YoY, a 149.12% increase.

Portfolio Pulse from mahesh@benzinga.com

May 20, 2024 | 9:39 am

NIO

TSLA

XPEV

Chinese EV makers Nio Inc (NYSE:NIO) and Xpeng Inc (NYSE:XPEV) are taking over 200 days to pay their suppliers, more than twice the time taken by Tesla Inc (NASDAQ:TSLA). Nio took 295 days and Xpeng took 221 days as of the end of 2023. Both companies have been struggling with profitability, reporting significant net losses and declining profit margins. Nio's and Xpeng's shares have dropped significantly year-to-date.

Portfolio Pulse from Anan Ashraf

May 20, 2024 | 9:35 am

LI

Li Auto shares are trading lower after the company reported worse-than-expected Q1 results and Q2 guidance.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 9:12 am

BIDU

TSLA

Fund manager Gary Black discusses the potential of Tesla's full self-driving (FSD) technology and the competition it may face from other automakers, including Baidu. He believes that fully autonomous vehicles are the future but doubts that Tesla will be the only player in the market. Baidu already has 500 robotaxis in service, with 50% capable of full autonomy. Tesla plans to unveil its robotaxi on August 8, with significant revenue expectations from this service.

Portfolio Pulse from Shanthi Rexaline

May 20, 2024 | 9:04 am